Under hypoxia-like conditions, cervical cancer cells increase SLC7A11 expression through KDM4A SUMOylation at the K471 site, which reduces H3K9me3-mediated repression of SLC7A11, thereby enhancing GPX4 levels and promoting ferroptosis resistance (39). Here, GPX4 is linked to cervical cancer.